Ipratropium Bromide: Clinical Trials

9 trials of Ipratropium Bromide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 6, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Ipratropium Bromide: new trials by email Literature Review of Ipratropium Bromide trials Research Report on Ipratropium Bromide

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)
Revefenacin, formoterol fumarate, Placebo (Sterile Normal Saline) - COPD Exacerbation
Phase 4Not yet recruitingUniversity of Tennessee Graduate School of Medicine2802026-11-122026-10-19
Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation
Nebulized Magnesium Sulfate, Nebulized isotonic saline, Nebulized Salbutamol - Asthma
Phase 4UnknownHospital General Naval de Alta Especialidad - Escuela Medico Naval1522015-09-012015-12-02
Ipratropium Bromide in Peri-Operative COPD
placebo, ipratropium bromide - Pulmonary Disease, Chronic Obstructive
Phase 4CompletedBoehringer Ingelheim1922013-10-012016-10-25
Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes
ipratropium bromide, Placebo - Bronchospasm, Exercise-Induced
Phase 4CompletedUniversity of California, San Francisco202012-12-012020-06-05
Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients
Salbutamol, ipratropium bromide - COPD
Phase 4CompletedUniversity Hospital, Antwerp62008-06-012009-06-02
Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness
ipratropium bromide, placebo - Asthma
Phase 4CompletedUniversity of Saskatchewan122008-01-012009-01-07
Budesonide Inhalation Suspension for Acute Asthma in Children
Budesonide inhalation suspension (0.5 mg/2mL) 2mg, albuterol (5mg/mL) 7.5 or 10mg, Prednisolone, prednisone, or methylprednisolone, Albuterol, ipratropium bromide - Asthma, Acute Asthma
Phase 4CompletedChildren's Hospital of Philadelphia1792006-12-012012-08-10
Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)
Ipratropium Bromide - Chronic Obstructive Pulmonary Disease (COPD)
Phase 4CompletedQueen's University322005-07-012011-04-19
Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children
Ipratropium bromide, Placebo, Salbutamol - Asthma
Phase 4TerminatedBoehringer Ingelheim31998-09-012014-09-10

Conditions studied

Asthma (4)  ·  Pulmonary Disease, Chronic Obstructive (3)  ·  Asthma, Exercise-Induced (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Disease (1)  ·  Dyspnea (1)  ·  Emergencies (1)  ·  Motor Activity (1)

Sponsors

Boehringer Ingelheim (2)  ·  Children's Hospital of Philadelphia (1)  ·  Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1)  ·  Queen's University (1)  ·  University Hospital, Antwerp (1)  ·  University of California, San Francisco (1)  ·  University of Saskatchewan (1)  ·  University of Tennessee Graduate School of Medicine (1)

Countries

United States (3)  ·  Canada (2)  ·  Belgium (1)  ·  China (1)  ·  Mexico (1)

Top investigators

Bryan D. Upham, M.D. (1)  ·  Cynthia J Mollen, M.D. (1)  ·  Denis E O'Donnell, MD (1)  ·  Donald W Cockcroft, MD (1)  ·  Mona Luke-Zeitoun (1)  ·  Wilfried A De Backer, MD PhD (1)

Results publications

PMID 11113831, PMID 11825832, PMID 19496252